Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
0.6001
+0.0151 (2.58%)
At close: Oct 23, 2026, 4:00 PM EDT
0.6000
-0.0001 (-0.02%)
After-hours: Oct 23, 2026, 7:31 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $43.5 million as of October 23, 2026. It is the 31,129th most valuable company in the world and the 4,706th biggest in the United States. Its market cap has decreased by 57.28% in one year.
Market Cap
43.50M
Enterprise Value
9.55M
1-Year Change
-57.28%
Global Rank
Country Rank
#4,706 United States
Category
ChartMarket Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $43.50M, a decrease of -91.11%. That is a compound annual growth rate of -35.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 43.50M | -50.39% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 46.07M |
| ImageneBio | 45.92M |
| Mereo BioPharma Group | 45.90M |
| Hyperion DeFi | 45.38M |
| Serina Therapeutics | 44.70M |
| INmune Bio | 42.74M |
| Alterity Therapeutics | 42.60M |
| Annovis Bio | 42.25M |